# EDGAR Filing Document

**Accession Number:** 0000855683
**File Stem:** 0001493152-26-021293
**Filing Date:** 2026-5
**Character Count:** 11845
**Document Hash:** 910d97e9ba0cac0251f0af30dd08ed07
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-021293.hdr.sgml**: 20260505

**ACCESSION NUMBER**: 0001493152-26-021293

**CONFORMED SUBMISSION TYPE**: 10-K/A

**PUBLIC DOCUMENT COUNT**: 55

**CONFORMED PERIOD OF REPORT**: 20251231

**FILED AS OF DATE**: 20260505

**DATE AS OF CHANGE**: 20260505

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** MILESTONE SCIENTIFIC INC.
- **CENTRAL INDEX KEY:** 0000855683
- **STANDARD INDUSTRIAL CLASSIFICATION:** ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 133545623
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-K/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14053
- **FILM NUMBER:** 26942831

**BUSINESS ADDRESS:**
- **STREET 1:** 220 SOUTH ORANGE AVENUE
- **CITY:** LIVINGSTON
- **STATE:** NJ
- **ZIP:** 07039
- **BUSINESS PHONE:** (973) 535-2717

**MAIL ADDRESS:**
- **STREET 1:** 220 SOUTH ORANGE AVENUE
- **CITY:** LIVINGSTON
- **STATE:** NJ
- **ZIP:** 07039

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** MILESTONE SCIENTIFIC INC/NJ
- **DATE OF NAME CHANGE:** 19970409

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** U S OPPORTUNITY SEARCH INC
- **DATE OF NAME CHANGE:** 19920703

?xml version='1.0' encoding='ASCII'?

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**Washington, D.C. 20549**

**FORM 10-K/A**

(Amendment No. 1)

(Mark One)

☒ **ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

**For the fiscal year ended December 31, 2025**

Or

☐ **TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**

For the transition period from

Commission file number 001-14053

**Milestone Scientific Inc.**

**(Exact name of registrant as specified in its charter)**

---

| | |
|:---|:---|
| **Delaware** | **13-3545623** |
| **State or other jurisdiction**<br> **of Incorporation or organization** | **(I.R.S. Employer**<br> **Identification No.)** |

---

**425 Eagle Rock Avenue, Roseland, NJ 07068**

**(Address of principal executive offices)**

**Registrant**'**s telephone number, including area code: 973-535-2717.**

**Securities registered pursuant to Section 12(b) of the Act:**

---

| | | |
|:---|:---|:---|
| **Title of each class** | **Symbol** | **Name of each exchange on which registered.** |
| **Common Stock, par value $0.001 per share** | **MLSS** | **NYSE American** |

---

**Securities registered pursuant to section 12(g) of the Act: NONE.**

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes ☒ No

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes ☐ No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes ☐ No

Indicate by check mark whether the registrant is a large, accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large, accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

---

| | | | |
|:---|:---|:---|:---|
| Large, accelerated filer | ☐ | Accelerated filer | ☐ |
| Non-accelerated filer | ☒ | Smaller reporting company | ☒ |
| Emerging Growth Company | ☐ |  |  |

---

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant has filed a report on and attestation to its management's assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report ☐

If securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐

Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to §240.10D-1(b). ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒

As of June 30, 2025, the last business day of the registrants most recently completed second fiscal quarter, the aggregate market value of the common stock held by non-affiliates of the issuer was $39,730,497 This amount is based on the closing price of $0.64 per share of the registrant's common stock as of such date, as reported on the NYSE American.

As of March 31, 2026, the registrant has a total of 80,453,116 shares of Common Stock, par value $0.001 per share outstanding.

**DOCUMENTS INCORPORATED BY REFERENCE**

None

**EXPLANATORY NOTE**

Milestone Scientific Inc. (the "Company") is filing this Amendment No. 1 on Form 10-K/A (this "Amendment") to amend its Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the Securities and Exchange Commission on March 31, 2026 (the "Original Form 10-K").

This Amendment is being filed solely to:

(i) include
 the entire Restated Certificate of Incorporation of the Company as Exhibit 3.1; and

(ii) restore
 the Company's Amended and Restated By-laws as Exhibit 3.2.

The Original Form 10-K correctly described the Company's Restated Certificate of Incorporation; however, the exhibit link inadvertently omitted a portion of the filed text. In addition, the Company's Amended and Restated By-laws, which were previously filed as Exhibit 3.2 to the Company's Form 10-K filed on April 1, 2025, were inadvertently omitted from the Original Form 10-K.

Pursuant to Rule 12b-15 under the Securities Exchange Act of 1934, as amended, this Amendment also contains new certifications by the principal executive officer and the principal financial officer of the Company as required by Section 302 of the Sarbanes-Oxley Act of 2002. Accordingly, Item 15 of Part IV of the Original Form 10-K is amended to include the currently dated certifications as exhibits. As no financial statements have been included in this Amendment and it does not contain or amend any disclosure with respect to Items 307 and 308 of Regulation S-K, paragraphs 3, 4 and 5 of the certifications have been omitted. The Company is not including certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 as no financial statements are being filed with this Amendment.

No other changes are being made to the Original Form 10-K. This Amendment does not amend, update or modify any other information contained in the Original Form 10-K and does not reflect any events occurring after the filing date of the Original Form 10-K.

**PART IV**

**Item 15. Exhibits, Financial Statement Schedules**

Part IV (Item 15) of the Original Form 10-K is hereby amended solely to add the following exhibits required to be filed in connection with this Amendment No. 1 on Form 10-K/A.

---

| | |
|:---|:---|
| Exhibit No. | Description |
| 3.1 | [Restated Certificate of Incorporation of Milestone, as amended as of March 10 2025 \*](ex3-1.htm) |
| 3.2 | [Amended and Restated By-laws of Milestone Scientific Inc. (1)](https://www.sec.gov/Archives/edgar/data/855683/000143774919006239/ex_138885.htm) |
| 31.1 | [Certification of Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended \*](ex31-1.htm) |
| 31.2 | [Certification of Principal Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended \*](ex31-2.htm) |
| 104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) |

---

\* Filed herewith. <br> (1) Incorporated by reference to the Company's Form 10-K filed with the SEC on April 1, 2019, as Exhibit 3.4.

**SIGNATURES**

In accordance with Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | <br> Milestone Scientific Inc. | <br> Milestone Scientific Inc. |
| May 5, 2026 |  |  |
|  | By: | */s/ Eric Hines* |
|  |  | Chief Executive Officer and Principal Executive Officer |
|  | By: | */s/ Keisha Harcum* |
|  |  | Vice President of Finance and Principal Accounting Officer |

---

## Exhibit 3.1

**Exhibit 3.1**

![](ex3-1_001.jpg)

![](ex3-1_002.jpg)

![](ex3-1_003.jpg)

![](ex3-1_004.jpg)

![](ex3-1_005.jpg)

![](ex3-1_006.jpg)

![](ex3-1_007.jpg)

![](ex3-1_008.jpg)

![](ex3-1_009.jpg)

![](ex3-1_010.jpg)

![](ex3-1_011.jpg)

![](ex3-1_012.jpg)

![](ex3-1_013.jpg)

![](ex3-1_014.jpg)

![](ex3-1_015.jpg)

![](ex3-1_016.jpg)

![](ex3-1_017.jpg)

![](ex3-1_018.jpg)

![](ex3-1_019.jpg)

![](ex3-1_020.jpg)

![](ex3-1_021.jpg)

![](ex3-1_022.jpg)

![](ex3-1_023.jpg)

![](ex3-1_024.jpg)

![](ex3-1_025.jpg)

![](ex3-1_026.jpg)

![](ex3-1_027.jpg)

![](ex3-1_028.jpg)

![](ex3-1_029.jpg)

![](ex3-1_030.jpg)

![](ex3-1_031.jpg)

![](ex3-1_032.jpg)

![](ex3-1_033.jpg)

![](ex3-1_034.jpg)

![](ex3-1_035.jpg)

![](ex3-1_036.jpg)

![](ex3-1_037.jpg)

![](ex3-1_038.jpg)

![](ex3-1_039.jpg)

![](ex3-1_040.jpg)

![](ex3-1_041.jpg)

## Exhibit 31.1

**Exhibit 31.1**

**Rule 13a-14(a)/15d-14(a) Certification**

I, Eric Hines, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I
 have reviewed this Amendment No. 1 to the Annual Report on Form 10-K for the fiscal year
 ended December 31, 2025, of Milestone Scientific Inc.

2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or
 omit to state a material fact necessary to make the statements made, in light of the
 circumstances under which such statements were made, not misleading with respect to
 the period covered by this report.

Date: May 5, 2026

---

| | |
|:---|:---|
| By: | */s/ Eric Hines* |
|  | Chief Executive Officer and Principal Executive Officer of Milestone Scientific Inc. |

---

## Exhibit 31.2

**Exhibit 31.2**

**Rule 13a-14(a)/15d-14(a) Certification**

I, Keisha Harcum, certify that:

&nbsp;&nbsp;&nbsp;&nbsp;1. I
 have reviewed this Amendment No. 1 to the Annual Report on Form 10-K for the fiscal year
 ended December 31, 2025, of Milestone Scientific Inc.

2. Based
 on my knowledge, this report does not contain any untrue statement of a material fact or
 omit to state a material fact necessary to make the statements made, in light of the
 circumstances under which such statements were made, not misleading with respect to
 the period covered by this report.

Date: May 5, 2026

---

| | |
|:---|:---|
| By: | */s/ Keisha Harcum* |
|  | Vice President of Finance and Principal Accounting Officer of Milestone Scientific Inc. |

---